{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:09:54Z","timestamp":1793711394393,"version":"4.6.1"},"reference-count":199,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.pharmthera.2013.07.004","type":"journal-article","created":{"date-parts":[[2013,7,13]],"date-time":"2013-07-13T06:01:23Z","timestamp":1373695283000},"page":"239-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":416,"title":["Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets?"],"prefix":"10.1016","volume":"140","author":[{"given":"Luc","family":"Rochette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Guilland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Lorgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Vergely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2013.07.004_bb0005","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(01)02063-X","article-title":"Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus","volume":"88","author":"Abbasi","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0010","doi-asserted-by":"crossref","first-page":"e9462","DOI":"10.1371\/journal.pone.0009462","article-title":"Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes","volume":"5","author":"Abhary","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/0264-6021:3570593","article-title":"Nitric oxide synthases: structure, function and inhibition","volume":"357","author":"Alderton","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.ATV.0000110785.96039.f6","article-title":"Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease","volume":"24","author":"Alp","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0025","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00018-012-1010-9","article-title":"The NOX toolbox: validating the role of NADPH oxidases in physiology and disease","volume":"69","author":"Altenhofer","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0030","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/sj.bjp.0702430","article-title":"A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo","volume":"126","author":"Andersson","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0035","doi-asserted-by":"crossref","first-page":"e36224","DOI":"10.1371\/journal.pone.0036224","article-title":"A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity","volume":"7","author":"Andreozzi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCULATIONAHA.110.985150","article-title":"Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling","volume":"124","author":"Antoniades","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0045","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/eurheartj\/ehp061","article-title":"Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis","volume":"30","author":"Antoniades","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0050","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/CIRCULATIONAHA.106.612325","article-title":"5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling","volume":"114","author":"Antoniades","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2010.10.029","article-title":"Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells","volume":"156","author":"Aoki","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0060","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/meta.2002.33349","article-title":"Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes","volume":"51","author":"Asagami","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2008.12.013","article-title":"Protein arginine methylation in mammals: who, what, and why","volume":"33","author":"Bedford","year":"2009","journal-title":"Mol Cell"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0891-5849(94)90147-3","article-title":"Plasma lipid peroxidation in critically ill patients: importance of mechanical ventilation","volume":"16","author":"Ben Baouali","year":"1994","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0075","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1515\/CCLM.2003.225","article-title":"Association of asymmetric dimethylarginine and endothelial dysfunction","volume":"41","author":"Boger","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.phrs.2009.07.001","article-title":"Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality\u2014an update on patient populations with a wide range of cardiovascular risk","volume":"60","author":"Boger","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0085","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.108.838268","article-title":"Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community","volume":"119","author":"Boger","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ajcn\/79.4.537","article-title":"Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity","volume":"79","author":"Bray","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0095","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chemphyslip.2010.07.004","article-title":"Effects of resveratrol on membrane biophysical properties: relevance for its pharmacological effects","volume":"163","author":"Brittes","year":"2010","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.ATV.16.1.44","article-title":"Regression or progression. Dependency on vascular nitric oxide","volume":"16","author":"Candipan","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0105","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/j.1476-5381.2011.01500.x","article-title":"Decreased production of neuronal NOS-derived hydrogen peroxide contributes to endothelial dysfunction in atherosclerosis","volume":"164","author":"Capettini","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0110","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1074\/jbc.M603606200","article-title":"Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function","volume":"282","author":"Cardounel","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0115","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1074\/jbc.M410241200","article-title":"Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase: differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin","volume":"280","author":"Cardounel","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0120","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/cvr\/cvq366","article-title":"Dietary nitrate attenuates oxidative stress, prevents cardiac and renal injuries, and reduces blood pressure in salt-induced hypertension","volume":"89","author":"Carlstrom","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0125","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1517\/14728222.2012.688030","article-title":"Protein arginine methyltransferases (PRMTs) as therapeutic targets","volume":"16","author":"Cha","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/cvr\/cvr233","article-title":"Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db\/db mice","volume":"92","author":"Cheang","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.abb.2009.03.015","article-title":"Two synthetic peptides corresponding to the proximal heme-binding domain and CD1 domain of human endothelial nitric-oxide synthase inhibit the oxygenase activity by interacting with CaM","volume":"486","author":"Chen","year":"2009","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0140","doi-asserted-by":"crossref","first-page":"23892","DOI":"10.1074\/jbc.M401853200","article-title":"Small molecule regulators of protein arginine methyltransferases","volume":"279","author":"Cheng","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0145","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pharmthera.2007.08.001","article-title":"l-arginine transporters in cardiovascular disease: a novel therapeutic target","volume":"116","author":"Chin-Dusting","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0150","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1472-8206.2003.00199.x","article-title":"Direct demonstration of nitric oxide formation in organs of rabbits treated by transdermal glyceryl trinitrate using an in vivo spin trapping technique","volume":"17","author":"Clermont","year":"2003","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0155","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1472-8206.1998.tb00947.x","article-title":"Plasma iron status and lipid peroxidation following thrombolytic therapy for acute myocardial infarction","volume":"12","author":"Cottin","year":"1998","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.niox.2011.04.004","article-title":"Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease","volume":"25","author":"Crabtree","year":"2011","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0165","doi-asserted-by":"crossref","first-page":"H1530","DOI":"10.1152\/ajpheart.00823.2007","article-title":"Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS","volume":"294","author":"Crabtree","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2010.03.001","article-title":"NO synthase: structures and mechanisms","volume":"23","author":"Daff","year":"2010","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0175","doi-asserted-by":"crossref","first-page":"H1762","DOI":"10.1152\/ajpheart.01205.2011","article-title":"Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine","volume":"302","author":"Davids","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0180","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0895-7061(02)02278-1","article-title":"Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension","volume":"15","author":"Delles","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00041433-199702000-00007","article-title":"Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease","volume":"8","author":"Duell","year":"1997","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0190","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1210\/en.2007-1558","article-title":"Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine\u2013dimethylaminohydrolase activity","volume":"149","author":"Ellger","year":"2008","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.pharmthera.2013.07.004_bb0195","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2337\/dc12-1084","article-title":"Diabetes impairs stem cell and proangiogenic cell mobilization in humans","volume":"36","author":"Fadini","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0200","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1021\/jm100416n","article-title":"Discovery and mechanistic study of a class of protein arginine methylation inhibitors","volume":"53","author":"Feng","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0205","first-page":"8","article-title":"ESR techniques for the detection of nitric oxide in vivo as an index of endothelial function","volume":"58","author":"Fink","year":"2006","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0210","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0215","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/CIRCULATIONAHA.107.717702","article-title":"Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction","volume":"118","author":"Fraccarollo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0220","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00395-009-0041-3","article-title":"The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury","volume":"104","author":"Frantz","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0225","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/heart.87.3.264","article-title":"Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia","volume":"87","author":"Fukuda","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0230","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nchembio.115","article-title":"Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase","volume":"4","author":"Garcin","year":"2008","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0235","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.freeradbiomed.2010.12.018","article-title":"Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders","volume":"50","author":"Gielis","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijcard.2010.09.004","article-title":"The impact of rapid atrial pacing on ADMA and endothelial NOS","volume":"154","author":"Goette","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0245","first-page":"575","article-title":"Homocysteine increase after acute myocardial infarction\u2014can it explain the differences between case-control and cohort studies?","volume":"21","author":"Gomes","year":"2002","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0250","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00004872-199715080-00015","article-title":"Nitric oxide synthase inhibitors and hypertension in children and adolescents","volume":"15","author":"Goonasekera","year":"1997","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0255","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.2741\/3174","article-title":"The mitochondrial free radical theory of ageing\u2014where do we stand?","volume":"13","author":"Gruber","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0260","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.drudis.2006.04.003","article-title":"Vascular NADPH oxidases as drug targets for novel antioxidant strategies","volume":"11","author":"Guzik","year":"2006","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cvr\/cvs182","article-title":"Arterial endothelial cells: still the craftsmen of regenerated endothelium","volume":"95","author":"Hagensen","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0270","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0891-5849(95)91457-3","article-title":"The definition and measurement of antioxidants in biological systems","volume":"18","author":"Halliwell","year":"1995","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cvr\/cvq412","article-title":"Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2","volume":"91","author":"Hamed","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cmdc.200800301","article-title":"Virtual screening and biological characterization of novel histone arginine methyltransferase PRMT1 inhibitors","volume":"4","author":"Heinke","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0285","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s001250051551","article-title":"Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus","volume":"43","author":"Heitzer","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0290","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.vph.2010.03.002","article-title":"Emodin and rhein inhibit LIGHT-induced monocytes migration by blocking of ROS production","volume":"53","author":"Heo","year":"2010","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0295","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1161\/01.CIR.100.14.1515","article-title":"A common variant of the endothelial nitric oxide synthase (Glu298\u2192Asp) is a major risk factor for coronary artery disease in the UK","volume":"100","author":"Hingorani","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0300","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1161\/01.CIR.0000091083.61609.DF","article-title":"Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine","volume":"108","author":"Holden","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0305","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10522-012-9379-2","article-title":"Tissue-specific and age-dependent expression of protein arginine methyltransferases (PRMTs) in male rat tissues","volume":"13","author":"Hong","year":"2012","journal-title":"Biogerontology"},{"issue":"7","key":"10.1016\/j.pharmthera.2013.07.004_bb0310","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1021\/jm4000984","article-title":"Structure-guided design of selective inhibitors of neuronal nitric oxide synthase","volume":"56","author":"Huang","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0315","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1021\/jm990111c","article-title":"N(omega)-nitroarginine-containing dipeptide amides. Potent and highly selective inhibitors of neuronal nitric oxide synthase","volume":"42","author":"Huang","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0320","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/HYPERTENSIONAHA.108.111120","article-title":"Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes","volume":"52","author":"Imanishi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0325","doi-asserted-by":"crossref","first-page":"H1058","DOI":"10.1152\/ajpheart.01103.2007","article-title":"Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice","volume":"294","author":"Jacobi","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0330","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1089\/ars.2009.2585","article-title":"Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets","volume":"11","author":"Jaquet","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0335","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1089\/ars.2006.8.1865","article-title":"Redefining oxidative stress","volume":"8","author":"Jones","year":"2006","journal-title":"Antioxid Redox Signal"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2013.07.004_bb0340","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1463-1326.2010.01266.x","article-title":"Redox compartmentalization and cellular stress","volume":"12","author":"Jones","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0345","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/oxfordjournals.aje.a112813","article-title":"An investigation of coronary heart disease in families. The Framingham offspring study","volume":"110","author":"Kannel","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0350","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tips.2008.10.003","article-title":"Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects","volume":"30","author":"Katusic","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0355","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijcard.2007.08.066","article-title":"Effect of angiotensin-converting enzyme inhibitor on serum asymmetric dimethylarginine and coronary circulation in patients with type 2 diabetes mellitus","volume":"132","author":"Kawata","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0360","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/01.CIR.0000060496.23144.A7","article-title":"Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects","volume":"107","author":"Kielstein","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0370","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1517\/13543776.2011.584870","article-title":"NADPH oxidase inhibitors: a patent review","volume":"21","author":"Kim","year":"2011","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0365","doi-asserted-by":"crossref","first-page":"584","DOI":"10.5483\/BMBRep.2010.43.9.584","article-title":"Maintenance of cellular tetrahydrobiopterin homeostasis","volume":"43","author":"Kim","year":"2010","journal-title":"BMB Rep"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0375","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.atherosclerosis.2010.11.014","article-title":"Time course of asymmetric dimethylarginine (ADMA) and oxidative stress in fructose-hypertensive rats: a model related to metabolic syndrome","volume":"214","author":"Korandji","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0380","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clinbiochem.2006.08.004","article-title":"Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction","volume":"40","author":"Korandji","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0385","doi-asserted-by":"crossref","first-page":"49133","DOI":"10.1074\/jbc.M011469200","article-title":"Structural basis for pterin antagonism in nitric-oxide synthase. Development of novel 4-oxo-pteridine antagonists of (6R)-5,6,7,8-tetrahydrobiopterin","volume":"276","author":"Kotsonis","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0390","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/14756366.2011.573480","article-title":"Designing modulators of dimethylarginine dimethylaminohydrolase (DDAH): a focus on selectivity over arginase","volume":"27","author":"Kotthaus","year":"2012","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0395","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pharmthera.2006.06.007","article-title":"Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential","volume":"113","author":"Krause","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2013.07.004_bb0400","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.atherosclerosis.2012.09.029","article-title":"A direct comparison of endothelial progenitor cell dysfunction in rat metabolic syndrome and diabetes","volume":"226","author":"Kuliszewski","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0405","doi-asserted-by":"crossref","first-page":"22546","DOI":"10.1074\/jbc.M302227200","article-title":"Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase","volume":"278","author":"Kuzkaya","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0410","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00005344-199901000-00012","article-title":"Electron spin resonance detection of nitric oxide generation in major organs from LPS-treated rats","volume":"33","author":"Lecour","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0415","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jvs.2010.04.085","article-title":"Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells","volume":"52","author":"Lee","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0420","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrd3358","article-title":"The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis","volume":"10","author":"Leiper","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0430","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.hrthm.2009.12.009","article-title":"Role of inflammation and oxidative stress in atrial fibrillation","volume":"7","author":"Li","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0425","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.bmc.2012.12.019","article-title":"Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase","volume":"21","author":"Li","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0435","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cccn.2003.10.006","article-title":"Effect of endogenous estrogen on endothelial function in women with coronary heart disease and its mechanism","volume":"339","author":"Li","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0440","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2796.2008.01965.x","article-title":"The molecular mechanisms of the thrombotic complications of atherosclerosis","volume":"263","author":"Libby","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0445","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.0000027109.14149.67","article-title":"Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase","volume":"106","author":"Lin","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0450","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/aps.2009.58","article-title":"The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats","volume":"30","author":"Linz","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0460","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbrc.2008.10.080","article-title":"Variance of DDAH\/PRMT\/ADMA pathway in atrial fibrillation dogs","volume":"377","author":"Liu","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0455","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2010.12.020","article-title":"JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation","volume":"19","author":"Liu","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0465","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0470","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","article-title":"Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock","volume":"32","author":"Lopez","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0475","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.atherosclerosis.2010.09.018","article-title":"The free oxygen radicals test (FORT) to assess circulating oxidative stress in patients with acute myocardial infarction","volume":"213","author":"Lorgis","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0480","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/HYPERTENSIONAHA.110.152959","article-title":"Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells","volume":"56","author":"Luo","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0485","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.tips.2011.07.006","article-title":"The renin\u2013angiotensin\u2013aldosterone system and glucose homeostasis","volume":"32","author":"Luther","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0490","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/CS20080079","article-title":"Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes","volume":"115","author":"Marcovecchio","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0495","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1021\/ja908544f","article-title":"Heme-coordinating inhibitors of neuronal nitric oxide synthase. Iron-thioether coordination is stabilized by hydrophobic contacts without increased inhibitor potency","volume":"132","author":"Martell","year":"2010","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0500","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1474-9726.2007.00271.x","article-title":"Abnormalities of mitochondrial functioning can partly explain the metabolic disorders encountered in sarcopenic gastrocnemius","volume":"6","author":"Martin","year":"2007","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0505","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/01.ATV.21.5.804","article-title":"3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: balance between transcriptional and posttranscriptional regulation","volume":"21","author":"Martinez-Gonzalez","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0510","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.bjp.0702298","article-title":"Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia","volume":"126","author":"Masuda","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0515","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1001\/archinte.163.16.1933","article-title":"Association of elevated homocysteine levels with a higher risk of recurrent coronary events and mortality in patients with acute myocardial infarction","volume":"163","author":"Matetzky","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0520","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/med.20005","article-title":"Biology and chemistry of the inhibition of nitric oxide synthases by pteridine-derivatives as therapeutic agents","volume":"24","author":"Matter","year":"2004","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0525","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00424-009-0765-9","article-title":"Cellular signaling and NO production","volume":"459","author":"Michel","year":"2010","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0530","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1034\/j.1600-0773.2000.d01-36.x","article-title":"Antioxidative and prooxidative action of stilbene derivatives","volume":"86","author":"Miura","year":"2000","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0535","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.99.9.1141","article-title":"Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis","volume":"99","author":"Miyazaki","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0540","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.yjmcc.2011.05.017","article-title":"Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure","volume":"51","author":"Moens","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0545","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1161\/CIRCULATIONAHA.107.737031","article-title":"Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy","volume":"117","author":"Moens","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0550","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1742-7843.2011.00785.x","article-title":"Reactive oxygen species and endothelial function\u2014role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases","volume":"110","author":"Montezano","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0555","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0008-6363(98)00146-1","article-title":"Intra-coronary administration of l-arginine aggravates myocardial stunning through production of peroxynitrite in dogs","volume":"40","author":"Mori","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0560","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mam.2004.09.003","article-title":"The role of nitric oxide in cardiovascular diseases","volume":"26","author":"Naseem","year":"2005","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0565","doi-asserted-by":"crossref","first-page":"309","DOI":"10.33549\/physiolres.931982","article-title":"Monoamine oxidase and semicarbazide-sensitive amine oxidase kinetic analysis in mesenteric arteries of patients with type 2 diabetes","volume":"60","author":"Nunes","year":"2011","journal-title":"Physiol Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0570","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db06-1772","article-title":"Expression of NG, NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers","volume":"57","author":"Onozato","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0575","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ajh.2008.218","article-title":"Metabolic syndrome: comparison of the two commonly used animal models","volume":"21","author":"Oron-Herman","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0580","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.freeradbiomed.2006.02.020","article-title":"NADPH oxidases are in part responsible for increased cardiovascular superoxide production during aging","volume":"40","author":"Oudot","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0585","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bjp.0707143","article-title":"Nitric oxide fails to confer endogenous antiarrhythmic cardioprotection in the primate heart in vitro","volume":"150","author":"Pabla","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0590","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0008-6363(00)00048-1","article-title":"l-arginine administration prevents reperfusion-induced cardiomyocyte hypercontracture and reduces infarct size in the pig","volume":"46","author":"Padilla","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0595","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/meta.2003.50048","article-title":"Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy","volume":"52","author":"Paiva","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0600","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1038\/sj.emboj.7601794","article-title":"Low levels of miR-92b\/96 induce PRMT5 translation and H3R8\/H4R3 methylation in mantle cell lymphoma","volume":"26","author":"Pal","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0605","doi-asserted-by":"crossref","first-page":"H3227","DOI":"10.1152\/ajpheart.00998.2007","article-title":"Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems","volume":"293","author":"Palm","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0610","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.niox.2011.03.002","article-title":"Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome","volume":"24","author":"Palomo","year":"2011","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0615","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.it.2010.01.006","article-title":"Protein arginine methylation: a new handle on T lymphocytes?","volume":"31","author":"Parry","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0620","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/ajh.2008.260","article-title":"Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients","volume":"21","author":"Pasini","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0625","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1189\/jlb.0610322","article-title":"Protective effects of apocynin, an inhibitor of NADPH oxidase activity, in splanchnic artery occlusion and reperfusion","volume":"88","author":"Paterniti","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0630","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/ATVBAHA.107.156786","article-title":"Twin layers of lightning: a new role for the chaperone Hsp90 in angiogenesis","volume":"28","author":"Pi","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0635","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.phrs.2009.07.016","article-title":"Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production","volume":"60","author":"Pope","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0640","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.mam.2005.07.001","article-title":"Iron, oxidative stress and human health","volume":"26","author":"Puntarulo","year":"2005","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0645","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1210\/jc.2003-030087","article-title":"Insulin resistance\/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease","volume":"88","author":"Reaven","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0650","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1476-5381.1990.tb14151.x","article-title":"Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo","volume":"101","author":"Rees","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0655","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/FJC.0b013e3181865f28","article-title":"Effects of angiotensin-1 converting enzyme inhibition on oxidative stress and bradykinin receptor expression during doxorubicin-induced cardiomyopathy in rats","volume":"52","author":"Richard","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0660","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2012.09.007","article-title":"Carbon monoxide: mechanisms of action and potential clinical implications","volume":"137","author":"Rochette","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0665","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000329951","article-title":"Atrial and vascular oxidative stress in patients with heart failure","volume":"27","author":"Rochette","year":"2011","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0670","doi-asserted-by":"crossref","first-page":"255","DOI":"10.59566\/IJBS.2008.4255","article-title":"Forgotten radicals in biology","volume":"4","author":"Rochette","year":"2008","journal-title":"Int J Biomed Sci"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0675","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.vph.2012.02.004","article-title":"Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases","volume":"57","author":"Roe","year":"2012","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0680","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-61779-382-0_17","article-title":"Redox equivalents and mitochondrial bioenergetics","volume":"810","author":"Roede","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0685","doi-asserted-by":"crossref","first-page":"23111","DOI":"10.1074\/jbc.M603671200","article-title":"Electron transfer by neuronal nitric-oxide synthase is regulated by concerted interaction of calmodulin and two intrinsic regulatory elements","volume":"281","author":"Roman","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0690","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1021\/jm050187a","article-title":"Selective substrate-based inhibitors of mammalian dimethylarginine dimethylaminohydrolase","volume":"48","author":"Rossiter","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0695","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.atherosclerosis.2011.09.011","article-title":"Circulating leukocyte telomere length and oxidative stress: a new target for statin therapy","volume":"219","author":"Saliques","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0700","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1139\/Y09-136","article-title":"Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages","volume":"88","author":"Sarna","year":"2010","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0705","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/00004872-199917110-00003","article-title":"Insulin, nitric oxide and the sympathetic nervous system: at the crossroads of metabolic and cardiovascular regulation","volume":"17","author":"Sartori","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0710","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/HYPERTENSIONAHA.107.093450","article-title":"Mineralocorticoid receptor blockade improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction","volume":"50","author":"Sartorio","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0715","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0040-8166(96)80067-X","article-title":"Immunohistochemical localization of facilitated-diffusion glucose transporters in rat pancreatic islets","volume":"28","author":"Sato","year":"1996","journal-title":"Tissue Cell"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0720","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1093\/ndt\/gfn357","article-title":"Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy","volume":"23","author":"Satoh","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0725","doi-asserted-by":"crossref","first-page":"F1144","DOI":"10.1152\/ajprenal.00221.2004","article-title":"NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy","volume":"288","author":"Satoh","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0730","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pharmthera.2010.02.005","article-title":"Modulating the NO generating system from a medicinal chemistry perspective: current trends and therapeutic options in cardiovascular disease","volume":"126","author":"Schade","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0735","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1124\/mol.112.079855","article-title":"Tetrahydrobiopterin protects soluble guanylate cyclase against oxidative inactivation","volume":"82","author":"Schmidt","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0740","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/01.RES.0000181286.44222.61","article-title":"Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study","volume":"97","author":"Schnabel","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0745","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.vph.2012.02.012","article-title":"Targeting NADPH oxidases in vascular pharmacology","volume":"56","author":"Schramm","year":"2012","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0750","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.295.1.58","article-title":"l-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial","volume":"295","author":"Schulman","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0755","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/ars.2007.1989","article-title":"Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension","volume":"10","author":"Schulz","year":"2008","journal-title":"Antioxid Redox Signal"},{"issue":"142\u2013147","key":"10.1016\/j.pharmthera.2013.07.004_bb0760","first-page":"155","article-title":"The nitric oxide pathway and oxidative stress in heart failure","volume":"8","author":"Searles","year":"2002","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0765","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pharmthera.2008.08.005","article-title":"NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition","volume":"120","author":"Selemidis","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0770","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.biocel.2007.10.011","article-title":"Hydrogen peroxide stimulates tetrahydrobiopterin synthesis through activation of the Jak2 tyrosine kinase pathway in vascular endothelial cells","volume":"40","author":"Shimizu","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0775","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10715760701885380","article-title":"Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats","volume":"42","author":"Sicard","year":"2008","journal-title":"Free Radic Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0780","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.nutr.26.061505.111320","article-title":"The clinical significance of asymmetric dimethylarginine","volume":"26","author":"Siroen","year":"2006","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0785","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/hc4601.098514","article-title":"Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine","volume":"104","author":"Stuhlinger","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0790","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.freeradbiomed.2012.02.046","article-title":"Off-target thiol alkylation by the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine (VAS2870)","volume":"52","author":"Sun","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0795","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/08830185.2012.665108","article-title":"Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases","volume":"31","author":"Svajger","year":"2012","journal-title":"Int Rev Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2013.07.004_bb0800","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1177\/1358836X0501000111","article-title":"ADMA metabolism and clearance","volume":"10","author":"Teerlink","year":"2005","journal-title":"Vasc Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0805","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.phrs.2009.08.002","article-title":"Cellular ADMA: regulation and action","volume":"60","author":"Teerlink","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0810","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/abio.2001.5575","article-title":"Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography","volume":"303","author":"Teerlink","year":"2002","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0815","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2008.03.020","article-title":"The chemical biology of nitric oxide: implications in cellular signaling","volume":"45","author":"Thomas","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0820","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2337\/db06-0699","article-title":"Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes","volume":"56","author":"Thum","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0825","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/iub.61","article-title":"Molecular mechanisms of oxidative stress-induced carcinogenesis: from epidemiology to oxygenomics","volume":"60","author":"Toyokuni","year":"2008","journal-title":"IUBMB Life"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0830","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10863-012-9429-0","article-title":"Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies","volume":"44","author":"Turan","year":"2012","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0835","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.RES.0000052990.68216.EF","article-title":"Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase","volume":"92","author":"Ueda","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0840","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.mam.2005.07.015","article-title":"Copper, oxidative stress, and human health","volume":"26","author":"Uriu-Adams","year":"2005","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0845","doi-asserted-by":"crossref","first-page":"23317","DOI":"10.1074\/jbc.271.38.23317","article-title":"p22phox is a critical component of the superoxide-generating NADH\/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells","volume":"271","author":"Ushio-Fukai","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0850","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0855","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.ATV.0000128897.54893.26","article-title":"Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway","volume":"24","author":"Vallance","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0860","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0865","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0891-5849(97)00282-7","article-title":"Influence of the severity of myocardial ischemia on the intensity of ascorbyl free radical release and on post-ischemic recovery during reperfusion","volume":"24","author":"Vergely","year":"1998","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0870","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.abb.2003.07.007","article-title":"Identification and quantification of free radicals during myocardial ischemia and reperfusion using electron paramagnetic resonance spectroscopy","volume":"420","author":"Vergely","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0875","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1124\/jpet.102.036871","article-title":"Postischemic recovery and oxidative stress are independent of nitric-oxide synthases modulation in isolated rat heart","volume":"303","author":"Vergely","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0880","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/10715760100301491","article-title":"Isolated perfused rat hearts release secondary free radicals during ischemia reperfusion injury. Cardiovascular effect of the spin trap alpha-phenyl N-tert-butylnitrone","volume":"35","author":"Vergely","year":"2001","journal-title":"Free Radic Res"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0885","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0890","doi-asserted-by":"crossref","first-page":"318087","DOI":"10.1155\/2012\/318087","article-title":"Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges","volume":"2012","author":"Vitecek","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0895","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1517\/17425250902785172","article-title":"Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease","volume":"5","author":"Wadham","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0905","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1021\/jm300521m","article-title":"Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation","volume":"55","author":"Wang","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0900","doi-asserted-by":"crossref","first-page":"R195","DOI":"10.1152\/ajpregu.90506.2008","article-title":"Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension","volume":"296","author":"Wang","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0910","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/BJ20110293","article-title":"Tetrahydrobiopterin: biochemistry and pathophysiology","volume":"438","author":"Werner","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0915","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/HYPERTENSIONAHA.111.187310","article-title":"Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables","volume":"59","author":"Wilcox","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0920","doi-asserted-by":"crossref","first-page":"656247","DOI":"10.1155\/2012\/656247","article-title":"Nitric oxide manipulation: a therapeutic target for peripheral arterial disease?","volume":"2012","author":"Williams","year":"2012","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0925","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1124\/jpet.107.128009","article-title":"Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling","volume":"325","author":"Wohlfart","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2013.07.004_bb0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3360001","article-title":"Arginine metabolism: nitric oxide and beyond","volume":"336","author":"Wu","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0935","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.yjmcc.2008.02.275","article-title":"The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium","volume":"44","author":"Wunderlich","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0940","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1124\/jpet.110.168724","article-title":"Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice","volume":"335","author":"Xia","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0945","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.106.684795","article-title":"Proteasome-dependent degradation of guanosine 5\u2032-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus","volume":"116","author":"Xu","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0950","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1021\/jm101071n","article-title":"Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase","volume":"54","author":"Xue","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0955","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2119\/molmed.2011.00103","article-title":"Tetrahydrobiopterin, l-arginine and vitamin C actsynergistically to decrease oxidative stress, increase nitricoxide and improve blood flow after induction of hindlimb ischemia in the rat","volume":"18","author":"Yan","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0960","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1476-5381.2011.01308.x","article-title":"AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats","volume":"163","author":"Yang","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0965","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ijc.25366","article-title":"Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers","volume":"128","author":"Yoshimatsu","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0970","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/1875397301005010072","article-title":"Targets in epigenetics: inhibiting the methyl writers of the histone code","volume":"5","author":"Yost","year":"2011","journal-title":"Curr Chem Genomics"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0975","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/157016108784911984","article-title":"The role of the methoxyphenol apocynin, a vascular NADPH oxidase inhibitor, as a chemopreventative agent in the potential treatment of cardiovascular diseases","volume":"6","author":"Yu","year":"2008","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0980","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/heartjnl-2011-301372","article-title":"Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure","volume":"98","author":"Zairis","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0985","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/ATVBAHA.108.162768","article-title":"Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction","volume":"28","author":"Zeller","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0995","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.yjmcc.2011.09.006","article-title":"Sub-cellular targeting of constitutive NOS in health and disease","volume":"52","author":"Zhang","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2013.07.004_bb0990","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1172\/JCI31093","article-title":"Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk","volume":"117","author":"Zhang","year":"2007","journal-title":"J Clin Invest"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725813001502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725813001502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T15:10:31Z","timestamp":1715699431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725813001502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":199,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0163725813001502"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2013.07.004","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets?","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2013.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}